Navigation Links
Growing Bioengineering to Attend Health Food Conferences in Tokyo and Madrid

Growing Bioengineering to Attend Health Food Conferences in Tokyo and Madrid -- SHANGHAI, Sept. 22 /PRNewswire-Asia-FirstCall/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals, Trade Show News Click to view news release full screen  

Growing Bioengineering to Attend Health Food Conferences in Tokyo and Madrid


SHANGHAI, Sept. 22 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT) ("China-Biotics" or "the Company"), the leading developer, manufacturer and distributor of probiotics products in China, today announced that its wholly-owned subsidiary Growing Bioengineering Company Limited, will attend health food conferences in Tokyo and Madrid later in 2010.

Growing Bioengineering will present at the Health Ingredients Japan 2010 conference in Tokyo, Japan. The annual exhibition is hosted by UBM Media Co., Ltd. and has been ongoing since 1989. An estimated 400 presenting companies will attend this year's event from Wednesday, October 13th to Friday, October 15th at the Tokyo Big Sight Exhibition Center in Tokyo, Japan.

Growing Bioengineering will also present at the 2010 Health Ingredients Europe conference in Madrid, Spain. The bi-annual exhibition is hosted by CMP Information. An estimated 140 exhibitors and over 9,000 visitors will present on subjects such as biotechnology, dietary supplements, food manufacturing, etc., from November 16th to November 18th at Ifema - Parque Ferial Juan Carlos in Madrid, Spain.

Mr. Jinan Song, Chairman and CEO of China-Biotics, commented, "The global probiotics market is expected to maintain robust growth in the future. We look forward to participating in more global industry events to help us stay abreast of the latest industry dynamics, market intelligence and help promote our brand to a global audience. We have established our international sales team to pursue global market opportunities, as we are confident in our product quality and pricing competitiveness. Our long-term corporate strategic direction remains to focus on growing our business in China and eventually diversifying our revenue source to overseas market."

About China-Biotics

China-Biotics, Inc. ("China-Biotics" or "the Company"), a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements in China. Through its wholly owned subsidiaries, Shanghai Shining Biotechnology Co., Ltd. and Growing Bioengineering (Shanghai) Co. Ltd., the Company develops and produces its proprietary product portfolio. Currently, the retail products are sold OTC mainly through large distributors to pharmacies and supermarkets in Shanghai, Jiangsu, and Zhejiang province. The Company also sells bulk products to institutional customers such as dairy and animal feed producers, as well as pharmaceutical companies. In February 2010, China-Biotics began its commercial production in China's largest probiotics production facility to meet growing demand in China. For more information, please visit .

For more information, please contact: China-Biotics, Inc. Travis Cai Chief Financial Officer Email: Grayling Kevin Theiss / Shiwei Yin Tel: +1-646-284-9409 Email:

SOURCE China-Biotics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioSpace Highlights Northern Californias Growing Life Science Region
2. China-Biotics Ranked Number 62 on FORTUNES 100 Fastest-Growing Companies List
3. SciQuest Makes the Inc. 500
4. 5000 List of Fastest-Growing Companies for Fourth Consecutive Year
5. BioPharm Systems Named to the 2010 Inc. 500
6. 5000 List of Fastest-Growing Companies in the U.S.
7. BioSpace Showcases the Midwests Growing Life Science Region
8. Precision Therapeutics Growing Rapidly as it Augments Research and Development Efforts
9. Data Demonstrate ViaMetrics-E Improves Implantation Rates in Single Embryo Transfer IVF Cycles, A Growing Trend in Infertility Treatment
10. DuPont Leader: Global Demand for Renewable Innovations Growing
11. Growing Demand for DuPont Renewable Products Drives Global Commercialization
Post Your Comments:
(Date:11/26/2015)... , England , November 26, 2015 ... Lightpoint Medical, an innovative medical device company specializing in imaging ... grant from the European Commission as part of the Horizon ... the company to carry out a large-scale clinical trial in ... -->      (Logo: , --> ...
(Date:11/25/2015)... , November 25, 2015 2 ... première fois les différences entre les souches bactériennes ... celles des êtres humains . Ces recherches ... et envisager la prise en charge efficace de ... diagnostiqués chez les chats .    --> ...
(Date:11/25/2015)... 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... and CEO of Neurocrine Biosciences, will be presenting at ... New York . .   ... approximately 5 minutes prior to the presentation to download ... presentation will be available on the website approximately one ...
(Date:11/25/2015)... , Nov. 25, 2015 Orexigen® Therapeutics, Inc. ... participate in a fireside chat discussion at the Piper ... York . The discussion is scheduled for Wednesday, ... .  A replay will be available for ... Stilwell  , Julie NormartVP, Corporate Communications and Business ...
Breaking Biology Technology:
(Date:11/10/2015)... 10, 2015 About signature ... helps to identify and verify the identity of ... as the secure and accurate method of authentication ... particular individual because each individual,s signature is highly ... when dynamic signature of an individual is compared ...
(Date:11/4/2015)... New York , November 4, 2015 ... to a new market report published by Transparency Market ... Share, Growth, Trends and Forecast 2015 - 2022", the global ... of US$ 30.3 bn by 2022. The market is ... the forecast period from 2015 to 2022. Rising security ...
(Date:10/29/2015)... 29, 2015  The J. Craig Venter Institute (JCVI) ... Synthesis and Biosecurity: Lessons Learned and Options for the ... and Human Services guidance for synthetic biology providers has ... --> --> Synthetic biology ... potential to pose unique biosecurity threats. It now is ...
Breaking Biology News(10 mins):